Colorectal cancer drug, Lonsurf, receives FDA approval

The U.S. Food and Drug Administration today approved Lonsurf (a pill that combines two drugs, trifluridine and tipiracil) for patients with an advanced form of colorectal cancer who are no longer responding to other therapies. "The past decade has brought a new understanding around colorectal cancer, in how we can both detect and treat this ["]